Alector, Inc. (ALEC) vs TRex Bio Inc. (TRXB)

Alector, Inc. ALEC 2.78 +9.88%
TRex Bio Inc. TRXB 13.70 +4.34%

Alector, Inc. and TRex Bio Inc. are both Biotechnology companies. Alector, Inc. and TRex Bio Inc. are of similar size ($376.7M and $360.4M).

Metric	ALEC	TRXB	Biotechnology median
P/E	7.06	—	10.96
P/S	1.61	—	9.52
P/B	2.40	—	2.23
Price to free cash flow	n/m	—	25.69
EV/EBITDA	3.89	—	0.68
EV/Sales	0.92	—	9.00
Earnings yield	14.16%	—	(32.09%)
Free cash flow yield	(53.54%)	—	(22.62%)

Metric	ALEC	TRXB	Biotechnology median
Gross margin	100.00%	—	68.51%
Operating margin	20.16%	—	0.00%
Net margin	23.87%	—	0.00%
Free cash flow margin	(86.31%)	—	0.00%
Return on equity	47.52%	—	(50.12%)
Return on assets	16.53%	—	(45.12%)
Return on invested capital	0.00%	—	0.00%

Metric	ALEC	TRXB	Biotechnology median
Revenue growth (TTM)	151.23%	—	6.78%
EPS growth (last fiscal year)	(13.01%)	—	29.88%
Revenue growth, 5-year CAGR	(0.05%)	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	ALEC	TRXB	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	4.10	—	4.74
Net debt to EBITDA	1.61	—	1.01

Metric	ALEC	TRXB	Biotechnology median
Dividend yield	—	—	0.40%
Payout ratio	—	—	—

Metric	ALEC	TRXB	Biotechnology median
Market cap	376.66m	360.36m	166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack